Approved Company
XenTech
Address: NO DATA
Website: NO DATA
Country(s): United States of America
Supported Region(s):
Description

XenTech The company is a contract research organization offering tumorgraft-based services in preclinical oncology. To foster therapeutic development in oncology, we perform preclinical pharmacology studies using one of the world’s largest and best characterized collection of patient-derived tumor xenograft models (so-called tumorgrafts) established without intermediary cell culture.

Service Category(s)
Key Service(s)
Life Science Sector
NO DATA
Certificates
NO DATA